肉毒毒素用于治疗慢性鼻麻醉症:一个病例报告
Brian A Moreno1, Juan Rodriguez-Puerto2, Kristin Haushalter3
1Dermatology, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
Cureus
|December 5, 2025
概括
麻醉症 (NP) 是一种慢性感官神经病变. 肌肉内注射的纳博胺毒素A在一种耐治疗病例中显示出显著的症状改善,这表明它有可能成为耐火NP.
科学领域:
- 神经学 神经学
- 皮肤病学 皮肤病学
背景情况:
- 鼻痛 (Notalgia paresthetica,简称NP) 是一种神经病症,导致上背部和不适.
- 像皮质类固醇和抗组胺剂这样的标准治疗方法对许多患者提供有限的缓解.
- 耐治疗的NP显著影响患者的生活质量.
研究的目的:
- 为了评估onabotulinumtoxinA (博托克斯) 治疗耐火性心痛的疗效paresthetica.
- 介绍一篇关于慢性NP患者成功使用Botox治疗的案例研究.
主要方法:
- 一个中年女性患有耐治疗NP的病例报告.
- 针对性肌肉内注射的芽毒素A (博托克斯) 给症状的上背部区域.
- 根据治疗方案评估患者的结果.
主要成果:
- 患者在第二轮博托克斯注射后,NP症状显著改善.
- 该疗法有效地控制了对传统疗法没有反应的不耐药症状.
- 由于症状缓解,生活质量得到改善.
结论:
- 玻尿酸毒素A (玻尿酸毒素) 可能作为一种可行的治疗选择,用于管理耐火性鼻痛.
- 这一案例表明,Botox可能对那些对标准NP治疗无反应的患者有好处.
- 需要进一步的研究来证实Botox在NP管理中的作用.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
859
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
859
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


